Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negat... von Manova, Manoela, Arabadjiev, Jeliazko, Mangaldzhiev, Radoslav, Dudov, Assen, Penchev, Daniel, Hemetsberger, Margit, Sharkov, Arkadi, Zidarova, Boryana, Apostolova, Dimitrina, Vasileva, Maria, Terezova, Silvia, Vlaskovska, Mila, Savova, Alexandra

Volltext

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phas... von Paz-Ares, Luis, Dvorkin, Mikhail, Chen, Yuanbin, Reinmuth, Niels, Hotta, Katsuyuki, Hochmair, Maximilian J, Özgüroğlu, Mustafa, Ji, Jun Ho, Bondarenko, Igor, Byrne, Natalie, Shire, Norah, Goldman, Jonathan W, Batagelj, Emilio, Casarini, Ignacio, Pastor, Anea Viviana, Hartl, Sylvia, Hochmair, Maximilian J, Lamprecht, Bernd, Dos Reis, Peo, Serodio da Rocha Baldotto, Clarissa, Venkova, Violetka, Bi, Minghong, Chen, Zhendong, Han, Zhigang, Hu, Yi, Li, Wei, Ma, Shenglin, Nan, Kejun, Shu, Yongqian, Wang, Kai, Yang, Nong, Zhang, Wei, Zhao, Jun, Zhao, Yanqiu, Zhou, Caicun, Zhou, Xiangdong, Skrickova, Jana, Hilgers, Werner, Moro-Sibilot, Denis, Bischoff, Helge, Lang, Susanne, Fülöp, Anea, Horváth, Zsolt, Laczó, Ibolya, Losonczy, György, Pápai Székely, Zsolt, Telekes, Anás, Bar, Jair, Gottfried, Maya, Heching, Norman Isaac, Bettini, Anna Cecilia, Minelli, Mauro, Roila, Fausto, Verderame, Francesco, Atagi, Shinji, Goto, Hisatsugu, Goto, Koichi, Hara, Yu, Hida, Toyoaki, Hotta, Katsuyuki, Kuyama, Shoichi, Morise, Masahiro, Nakahara, Yasuharu, Okamoto, Isamu, Shinoda, Masahiro, Umemura, Shigeki, Heniks, Lizza, Ungureanu, Anei, Luft, Alexander, Sakaeva, Dina, Smolin, Alexey, Statsenko, Galina, Vasilyev, Alexander, Vladimirova, Lyubov, Chovanec, Jozef, Urda, Michal, Ji, Jun Ho, Lee, Kyung Hee, Isla Casado, Dolores, Ponce Aix, Santiago, Hsia, Te-Chun, Wu, Shang-Yin, Çiçin, Irfan, Göksel, Tuncay, Özgüroğlu, Mustafa, Adamchuk, Hryhoriy, Bondarenko, Igor, Kryzhanivska, Anna, Shevnia, Serhii, Trukhin, Dmytro, Ursol, Grygorii, Voitko, Oleksandr, Vynnychenko, Ihor, Chen, Yuanbin, Chua, Winston, Dakhil, Shaker, Goldman, Jonathan W, Lakhanpal, Shailena, Powell, Steven, Stilwill, Joseph

Volltext

Late 68Ga PSMA-positive Pancreatic Metastasis From Renal Cell Carcinoma in a Patient with Metastatic Prostate Cancer: A Mission Impossible von Mateva, Gabriela, Novoselska, Nikolina, Dudov, Assen, Garcheva-Tsacheva, Marina, Bochev, Pavel

Volltext

Late 68 Ga PSMA-positive Pancreatic Metastasis From Renal Cell Carcinoma in a Patient with Metastatic Prostate Cancer: A Mission Impossible von Mateva, Gabriela, Novoselska, Nikolina, Dudov, Assen, Garcheva-Tsacheva, Marina, Bochev, Pavel

Volltext

Late Ga PSMA]-positive Pancreatic Metastasis From Renal Cell Carcinoma in a Patient with Metastatic Prostate Cancer: A Mission Impossible von Mateva, Gabriela, Novoselska, Nikolina, Dudov, Assen, Garcheva-Tsacheva, Marina, Bochev, Pavel

Volltext

Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma: Updated results from the FAST trial von Sahin, Ugur, Tureci, Özlem, Manikhas, Georgy M., Lordick, Florian, Rusyn, Andriy, Vynnychenko, Ihor, Dudov, Assen, Bazin, Igor, Bondarenko, Igor, Melichar, Bohuslav, Dhaene, Karl, Wiechen, Kai, Maurus, Daniel, Schuler, Martin H., Al-Batran, Salah-Eddin

Volltext

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Stud... von Trukhin, Dmytro, Poddubskaya, Elena, Andric, Zoran, Makharadze, Tamta, Bellala, Ravi Shankar, Charoentum, Chaiyut, Yañez Ruiz, Eduardo P., Fulop, Andrea, Hyder Ali, Irfhan Ali, Syrigos, Kostas, Katgi, Nuran, Lopez Chuken, Yamil Alonso, Rumyana, Ilieva, Reyes-Igama, Jasmin, Costamilan, Rita de Cassia, Del Campo García, Ana, Florez, Amalia, Paravisini, Alexandra, Millan, Susana

Volltext

Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers: Results from the FAST study von Schuler, Martin H., Al-Batran, Salah-Eddin, Zvirbule, Zanete, Manikhas, Georgy, Lordick, Florian, Rusyn, Andriy V., Vynnychenko, Ihor, Dudov, Assen, Bazin, Igor, Melichar, Bohuslav, Dhaene, Karl, Wiechen, Kai, Maurus, Daniel, Tureci, Özlem, Sahin, Ugur

Volltext

FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody,... von Al-Batran, Salah-Eddin, Schuler, Martin H., Zvirbule, Zanete, Manikhas, Georgiy, Lordick, Florian, Rusyn, Andriy, Vynnyk, Yuriy, Vynnychenko, Ihor, Fadeeva, Natalia, Nechaeva, Marina, Dudov, Assen, Gotovkin, Evgeny, Pecheniy, Alexander, Bazin, Igor, Bondarenko, Igor, Melichar, Bohuslav, Mueller, Christian, Huber, Christoph, Tureci, Oezlem, Sahin, Ugur

Volltext

FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody,... von Al-Batran, Salah-Eddin, Schuler, Martin H., Zvirbule, Zanete, Manikhas, Georgiy, Lordick, Florian, Rusyn, Andriy, Vynnyk, Yuriy, Vynnychenko, Ihor, Fadeeva, Natalia, Nechaeva, Marina, Dudov, Assen, Gotovkin, Evgeny, Pecheniy, Alexander, Bazin, Igor, Bondarenko, Igor, Melichar, Bohuslav, Mueller, Christian, Huber, Christoph, Tureci, Oezlem, Sahin, Ugur

Volltext

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin’s Lymphoma or... von Quinn, David I., Nemunaitis, John, Fuloria, Jyotsna, Britten, Carolyn D., Gabrail, Nashat, Yee, Lorrin, Acharya, Milin, Chan, Kai, Cohen, Nadine, Dudov, Assen

Volltext